Andrew Melville - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Andrew Melville's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Andrew Melville

Andrew Melville

Verified

Author, Block Scholes Research

Final Covers

SAP S4Hana, RPA 3DX-Experience, TeamCenterDigital Transformation & Innovation: AI-driven solutions and process optimization, automationProduct Lifecycle Management (PLM): Enovia

Doesn’t Cover

Let’s just say I’m sure the sports world feels cheated by my obvious lack of passion.

Journalist Type

-

Seniority Positions

-

Medium Formats

Content

Total articles 4

  • Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study

    By Fiona Rayner, Shaun Hiu, Andrew Melville, Theophile Bigirumurame| BMJ Open Verified DiscussionBIO-FLARE is an experimental medicine study designed to provide insights into the biological processes that trigger episodes of flare in patients with RA. The ability to compare patients who remain in remission on DMARD cessation with those who flare provides a well-controlled biological model.

    By Fiona Rayner, Shaun Hiu, Andrew Melville, Theophile Bigirumurame · BMJ Open

    Mar. 31, 2025

  • ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’

    By Maya H. Buch, Andrew Melville, Dennis McGonagle, Musculoskeletal Medicine| Annals of the Rheumatic Diseases Verified ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ Free http://orcid.org/0000-0002-8962-5642Maya H Buch1,2, http://orcid.org/0000-0002-2604-9123Andrew Melville1,2, Dennis G McGonagle1,2 1 Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK 2 NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK Correspondence...

    By Maya H. Buch, Andrew Melville, Dennis McGonagle, Musculoskeletal Medicine · Annals of the Rheumatic Diseases

    Oct. 12, 2020

  • Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study

    By Fiona Rayner, Shaun Hiu, Andrew Melville, Theophile Bigirumurame| BMJ Open Verified DiscussionBIO-FLARE is an experimental medicine study designed to provide insights into the biological processes that trigger episodes of flare in patients with RA. The ability to compare patients who remain in remission on DMARD cessation with those who flare provides a well-controlled biological model.

    By Fiona Rayner, Shaun Hiu, Andrew Melville, Theophile Bigirumurame · BMJ Open

    Mar. 31, 2025

As seen in

Company Info

Block Scholes Research

Corvallis, Oregon, United States

+1 541-737-1000